Search INFU
InfuSystem Holdings, Inc.
NYSE American · CIK 1337013
Last close13.16
Daily change+0.34 (2.65%)
10 Years gain+378.55%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
INFU · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
63.4Momentum
66.2Acceleration
71.3Confidence
91.0Annual Revenue17
Quarterly Revenue58
Annual CFO15
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth12.7 / 25
Quality19.7 / 25
Capital Efficiency9.7 / 20
Balance Sheet9.5 / 15
Shareholder Economics8.5 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 4.0233 percentage points.
Operating leverageOperating margin improved by 3.2427 percentage points.
ROIC expansionROIC improved by 5.7698 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 0.971%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM4.02%OK
Revenue CAGR 3Y9.28%OK
Gross Margin57.15%OK
Operating Margin9.31%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC12.4%OK
Incremental Operating Margin 3Y40.48%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-0.97%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $143.44M | $80.30M | $11.92M | $24.41M | $23.85M | 55.98% | 8.31% | 16.63% | 10.02% | 21.1M |
| 2025 FY Dec 31, 2024 | $134.86M | $70.40M | $6.89M | $20.46M | $19.37M | 52.2% | 5.11% | 14.36% | 5.53% | 21.71M |
| 2024 FY Dec 31, 2023 | $125.79M | $63.11M | $4.09M | $11.22M | $10.20M | 50.17% | 3.25% | 8.11% | 3.28% | 21.65M |
| 2023 FY Dec 31, 2022 | $109.91M | $60.56M | $1.65M | $17.52M | $16.54M | 55.1% | 1.5% | 15.04% | 1.33% | 21.55M |
| 2023 FY Dec 31, 2021 | $102.38M | $58.54M | $2.82M | $18.32M | $17.34M | 57.17% | 2.75% | 16.93% | 3.25% | 22.05M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $143.11M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-052462, 0001628280-25-048869 |
| Revenue Growth TTM | 4.02% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-052462, 0001628280-25-048869 |
| Revenue CAGR 3Y | 9.28% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-012804 |
| Revenue CAGR 5Y | 8.05% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-012804 |
| Gross Profit CAGR 3Y | 9.86% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-012804 |
| Operating Income Growth | 59.56% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-052462, 0001628280-25-048869 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 57.15% | Gross Profit / Revenue | OK | 0001628280-26-052462, 0001628280-25-048869 |
| Operating Margin | 9.31% | Operating Income / Revenue | OK | 0001628280-26-052462, 0001628280-25-048869 |
| ROIC | 12.4% | NOPAT / Average Invested Capital | OK | 0001628280-26-052462, 0001628280-25-048869 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-052462 |
| Current Ratio | 2.5x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.05x | (Cash + Short-term Investments) / Total Debt | OK | 0001628280-26-052462 |
| Revenue per Diluted Share | $6.84 | Revenue / Diluted Shares | OK | 0001628280-26-052462, 0001628280-25-048869 |